RXQ Compounding LLC recalls fentaNYL 0.05MG/ML INJ SOL (PF), 55ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 4570
Recalled August 14, 2019 · FDA recall D-1658-2019 · RXQ Compounding
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
N/A
Sold at
Nationwide USA
Description
Lack of Assurance of Sterility
Product
fentaNYL 0.05MG/ML INJ SOL (PF), 55ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0118-55
Manufacturer(s)
RXQ Compounding LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →